COMMUNIQUÉS West-GlobeNewswire

Courtney Caputo Named Chair of the National Board of Directors at the Epilepsy Foundation of America
08/07/2025
BOWIE, Md., July 08, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Courtney Caputo as Chair of the National Board of Directors. Her personal connection to [...]
Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
08/07/2025
Accepted IND application allows for development program to move directly to a Phase 2 pivotal registration clinical trial Phase 2 clinical trial initiation anticipated in first half of 2026 Pediatric cardiomyopathies [...]
Medicines for Poland lance un avertissement : sans usines pharmaceutiques, aucune guerre ne pourra être gagnée en Europe
08/07/2025
BRUXELLES, 08 juill. 2025 (GLOBE NEWSWIRE) -- Une analyse de l’impact de la guerre sur la disponibilité des médicaments en Ukraine aboutit à la conclusion suivante : un fonds relevant du budget de l’UE doit être créé en [...]
Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data
08/07/2025
- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins - Series B round in planning to support pivotal U.S. trial - New CEO appointment signals next phase of growth and expansion LAUSANNE, [...]
WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause
08/07/2025
With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief Medical Officer The Company is advancing its first integrated women’s [...]
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
08/07/2025
- NDA assigned a Target Action Date of February 25, 2026 - - Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: [...]
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
08/07/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients [...]
Novartis receives approval for first malaria medicine for newborn babies and young infants
08/07/2025
Coartem ® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by [...]
AB Science annonce le succès d'un placement privé de 1,925 millions d'euros
08/07/2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE D’ENVIRON 1,925 MILLION D’EUROS Paris, 8 juillet 2025, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce [...]
AB Science announces the successful completion of a EUR 1.925 million private placement
08/07/2025
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
08/07/2025
With a patent-pending formula and international expansion underway, BioAro positions itself as a front-runner in the multi-billion-dollar longevity and wellness sector CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE [...]
Les Émirats arabes unis approuvent le complément Longevity+ de BioAro, ouvrant la voie à un fort potentiel sur le marché mondial de la santé préventive
08/07/2025
Avec une formule en instance de brevet et une expansion internationale en cours, BioAro se positionne comme un leader de premier plan dans le secteur du bien-être et de la longévité, un marché de plusieurs milliards de [...]
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
08/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to [...]
Inventiva receives $10 million milestone payment from CTTQ
07/07/2025
Daix (France), New York City (New York, United States), July 7, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Inventiva receives $10 million milestone payment from CTTQ
07/07/2025
Daix (France), New York City (New York, United States), July 7, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07/07/2025
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
07/07/2025
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., July 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology [...]
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ENDO 2025
07/07/2025
COPENHAGEN, Denmark, July 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being held July 12-15, 2025, in [...]
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
07/07/2025
Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- [...]

Pages